130 related articles for article (PubMed ID: 1821195)
1. Manifestations of graft-versus-host disease following allogenic bone marrow transplantation.
Arocker-Mettinger E; Skorpik F; Grabner G; Hinterberger W; Gadner H
Eur J Ophthalmol; 1991; 1(1):28-32. PubMed ID: 1821195
[TBL] [Abstract][Full Text] [Related]
2. Ocular complications of bone marrow transplantation.
Livesey SJ; Holmes JA; Whittaker JA
Eye (Lond); 1989; 3 ( Pt 3)():271-6. PubMed ID: 2693135
[TBL] [Abstract][Full Text] [Related]
3. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb HJ
Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
5. Late ocular complications after bone marrow transplantation.
Tichelli A
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S79-82. PubMed ID: 8177722
[TBL] [Abstract][Full Text] [Related]
6. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
7. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation.
Rojas B; Cuhna R; Zafirakis P; Ramirez JM; Lizan-garciía M; Zhao T; Foster CS
Exp Eye Res; 2005 Sep; 81(3):313-25. PubMed ID: 16129099
[TBL] [Abstract][Full Text] [Related]
8. Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival.
Nevo S; Enger C; Swan V; Wojno KJ; Fuller AK; Altomonte V; Braine HG; Noga SJ; Vogelsang GB
Transplantation; 1999 Mar; 67(5):681-9. PubMed ID: 10096522
[TBL] [Abstract][Full Text] [Related]
9. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Flowers ME; Parker PM; Johnston LJ; Matos AV; Storer B; Bensinger WI; Storb R; Appelbaum FR; Forman SJ; Blume KG; Martin PJ
Blood; 2002 Jul; 100(2):415-9. PubMed ID: 12091330
[TBL] [Abstract][Full Text] [Related]
10. Sjögren-like syndrome after bone marrow transplantation.
Kosrirukvongs P; Chirapapaisan N; Visuthisakchai S; Issaragrisil S; Gonggetyai V
J Med Assoc Thai; 2008 Nov; 91(11):1739-47. PubMed ID: 19127798
[TBL] [Abstract][Full Text] [Related]
11. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
12. Ocular manifestations of graft-vs-host disease.
Franklin RM; Kenyon KR; Tutschka PJ; Saral R; Green WR; Santos GW
Ophthalmology; 1983 Jan; 90(1):4-13. PubMed ID: 6338437
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
14. Less graft-versus-host disease after rabbit antithymocyte globulin conditioning in unrelated bone marrow transplantation for leukemia and myelodysplasia: comparison with matched related bone marrow transplantation.
Atta EH; de Oliveira DC; Bouzas LF; Nucci M; Abdelhay E
PLoS One; 2014; 9(9):e107155. PubMed ID: 25188326
[TBL] [Abstract][Full Text] [Related]
15. Ocular manifestations of acute graft versus host disease after allogeneic bone marrow transplant.
Colón-Acevedo B; Rivera-Román L; Candelario N; Sánchez J
Bol Asoc Med P R; 2014; 106(2):30-2. PubMed ID: 25065048
[TBL] [Abstract][Full Text] [Related]
16. Multifocal choroiditis after allogenic bone marrow transplantation.
Alvarez MT; Hernáez JM; Ciancas E; Figueroa MS
Eur J Ophthalmol; 2002; 12(2):135-7. PubMed ID: 12022287
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous manifestations of graft versus host disease in a population of pediatric and young adults patients].
Martino C; Calvano R; Boggio P; Scacchi MF; Sojo M; Carbajosa A; Makiya M; Giachetti A
Arch Argent Pediatr; 2020 Oct; 118(5):e468-e475. PubMed ID: 32924403
[TBL] [Abstract][Full Text] [Related]
18. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Slavin S; Nagler A; Naparstek E; Kapelushnik Y; Aker M; Cividalli G; Varadi G; Kirschbaum M; Ackerstein A; Samuel S; Amar A; Brautbar C; Ben-Tal O; Eldor A; Or R
Blood; 1998 Feb; 91(3):756-63. PubMed ID: 9446633
[TBL] [Abstract][Full Text] [Related]
19. Ocular manifestations in bone marrow transplantation.
Spires R
J Ophthalmic Nurs Technol; 1993; 12(5):208-10. PubMed ID: 8301680
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestations of graft versus host disease.
Anderson NG; Regillo C
Curr Opin Ophthalmol; 2004 Dec; 15(6):503-7. PubMed ID: 15523196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
